/chembl/compound/{name}Look Up Compound Bioactivity
Look up compound bioactivity from ChEMBL 36
Only in Galen
Direct queries against ChEMBL 36 (30.7 GB) — the world's largest open drug bioactivity database with 2.4M+ compounds. Returns structured activity measurements (IC50, Ki, EC50), mechanisms of action, and clinical indications. This is real experimental pharmacology data, not an LLM summary of a drug's Wikipedia page.
Parameters
Path Parameters
| Name | Type | Req | Description |
|---|---|---|---|
name | string | Compound or drug name to look up Example: |
Response Schema
compoundobjectCore compound metadata from ChEMBLchembl_idstringChEMBL identifier (e.g. CHEMBL553)namestringPreferred compound namemax_phaseintegerHighest clinical trial phase reached (4 = approved)molecule_typestringMolecule classification (e.g. Small molecule, Antibody)first_approvalintegerYear of first regulatory approval, if applicablesmilesstringCanonical SMILES structural representationinchi_keystringInChIKey hash for structure-based lookupsactivitiesarrayExperimental bioactivity measurements against biological targetstarget_namestringHuman-readable target nametarget_chembl_idstringChEMBL identifier for the targetactivity_typestringMeasurement type (IC50, Ki, EC50, Kd)valuefloatActivity measurement valueunitsstringUnits of measurement (typically nM)pchembl_valuefloatStandardized -log10(molar) potency for cross-comparisonorganismstringSource organism for the target (e.g. Homo sapiens)mechanismsarrayKnown mechanisms of actionmechanismstringMechanism descriptionaction_typestringAction type (e.g. INHIBITOR, ANTAGONIST)target_namestringName of the molecular targettarget_chembl_idstringChEMBL identifier for the mechanism targetindicationsarrayClinical indications (diseases the drug is approved or investigated for)diseasestringDisease or condition namemesh_idstringMeSH descriptor ID for the indicationmax_phaseintegerHighest phase reached for this specific indicationefo_termstringExperimental Factor Ontology termExample Request
import requests
resp = requests.get(
"https://research.usegalen.com/api/v1/chembl/compound/erlotinib",
headers={"X-API-Key": "YOUR_API_KEY"}
)
data = resp.json()
# Print primary target activities
for act in data["activities"][:5]:
print(f"{act['target_name']}: {act['activity_type']} = {act['value']} {act['units']}")Example Response
{
"compound": {
"chembl_id": "CHEMBL553",
"name": "ERLOTINIB",
"max_phase": 4,
"molecule_type": "Small molecule",
"first_approval": 2004,
"smiles": "C=Cc1cccc(NC(=O)c2cc(OC)c(OC)c(OC)c2)c1",
"inchi_key": "AAKJLRGGTJKAMG-UHFFFAOYSA-N"
},
"activities": [
{
"target_name": "Epidermal growth factor receptor erbB1",
"target_chembl_id": "CHEMBL203",
"activity_type": "IC50",
"value": 2,
"units": "nM",
"pchembl_value": 8.7,
"organism": "Homo sapiens"
},
{
"target_name": "Epidermal growth factor receptor erbB1",
"target_chembl_id": "CHEMBL203",
"activity_type": "Ki",
"value": 0.7,
"units": "nM",
"pchembl_value": 9.15,
"organism": "Homo sapiens"
},
{
"target_name": "Tyrosine-protein kinase ABL1",
"target_chembl_id": "CHEMBL1862",
"activity_type": "IC50",
"value": 4200,
"units": "nM",
"pchembl_value": 5.38,
"organism": "Homo sapiens"
}
],
"mechanisms": [
{
"mechanism": "Epidermal growth factor receptor (ErbB1) inhibitor",
"action_type": "INHIBITOR",
"target_name": "Epidermal growth factor receptor erbB1",
"target_chembl_id": "CHEMBL203"
}
],
"indications": [
{
"disease": "Non-Small Cell Lung Cancer",
"mesh_id": "D002289",
"max_phase": 4,
"efo_term": "non-small cell lung carcinoma"
},
{
"disease": "Pancreatic Neoplasms",
"mesh_id": "D010190",
"max_phase": 4,
"efo_term": "pancreatic carcinoma"
}
]
}Try It
Path Parameters
Compound or drug name to look up
GET https://research.usegalen.com/api/v1/chembl/compound/{name}Related Endpoints